ACEA Biosciences
Jia Liu has over 36 years of work experience in the pharmaceutical and biosciences industry. Jia started their career in 1984 as a QC Manager at Xian-Janssen (Johnson & Johnson, China). In 1995, they joined Agouron Pharmaceuticals as a Research Scientist and later became a Principal Scientist at Pfizer/Warner Lambert/Agouron. From 1999 to 2009, Jia worked at Pfizer as a Principal Scientist. In 2010, they joined ACEA Biosciences as a Sr. Director of Formulation and Analytical.
Jia Liu attended the University of Minnesota from 1992 to 1995, although it is not known whether they obtained a degree or pursued a particular field of study during this period. Later on, from 2002 to 2004, Jia Liu pursued an MBA in Global Management at the University of Phoenix.
This person is not in any teams
ACEA Biosciences
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.The Life TechnologyBusiness Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.